International business machines corporation (20240290483). BIOMARKER PRIORITIZATION FOR EDGE COMPUTING RESOURCE MANAGEMENT simplified abstract

From WikiPatents
Revision as of 09:43, 5 September 2024 by Wikipatents (talk | contribs) (Creating a new page)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search

BIOMARKER PRIORITIZATION FOR EDGE COMPUTING RESOURCE MANAGEMENT

Organization Name

international business machines corporation

Inventor(s)

Paul R. Bastide of Ashland MA (US)

SAMIR Nasser of Durham NC (US)

BIOMARKER PRIORITIZATION FOR EDGE COMPUTING RESOURCE MANAGEMENT - A simplified explanation of the abstract

This abstract first appeared for US patent application 20240290483 titled 'BIOMARKER PRIORITIZATION FOR EDGE COMPUTING RESOURCE MANAGEMENT

The abstract of this patent application describes a method, computer system, and computer program product for biomarker prioritization. The method involves collecting data from a medical device associated with a user, identifying biomarkers generated by the device, associating biomarkers with concerned components or medical models, assigning biomarker priorities, generating a schedule for resource processing based on these priorities, and executing the schedule.

  • Collecting data from a medical device associated with a user
  • Identifying biomarkers generated by the medical device
  • Associating biomarkers with concerned components or medical models
  • Assigning biomarker priorities to related components
  • Generating a schedule for resource processing based on biomarker priorities
  • Executing the schedule for resource processing

Potential Applications: - Healthcare industry for personalized medicine - Research institutions for data analysis - Pharmaceutical companies for drug development

Problems Solved: - Prioritizing biomarkers for efficient resource allocation - Enhancing personalized healthcare - Improving data analysis in medical research

Benefits: - Optimized resource allocation - Enhanced patient care - Accelerated drug development process

Commercial Applications: Title: "Biomarker Prioritization Technology for Personalized Healthcare" This technology can be used in healthcare facilities, research institutions, and pharmaceutical companies to streamline data analysis processes, improve patient care, and expedite drug development.

Questions about Biomarker Prioritization Technology: 1. How does biomarker prioritization benefit personalized healthcare? - Biomarker prioritization helps in identifying key indicators for individualized treatment plans, leading to better patient outcomes.

2. What are the potential challenges in implementing biomarker prioritization technology in healthcare settings? - Some challenges may include data integration, privacy concerns, and the need for specialized training for healthcare professionals.


Original Abstract Submitted

according to one embodiment, a method, computer system, and computer program product for biomarker prioritization is provided. the embodiment may include collecting data from a medical device associated with a user. the embodiment may also include identifying, for each type of data, at least one biomarker generated by the medical device associated with the user. the embodiment may further include associating each biomarker with a concerned component and/or a medical model. the embodiment may also include assigning a biomarker priority to a related component. the embodiment may further include generating a schedule for resource processing based on the biomarker priority. the embodiment may also include executing the schedule for resource processing.